These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 23359207

  • 1. Regulation of HGF expression by ΔEGFR-mediated c-Met activation in glioblastoma cells.
    Garnett J, Chumbalkar V, Vaillant B, Gururaj AE, Hill KS, Latha K, Yao J, Priebe W, Colman H, Elferink LA, Bogler O.
    Neoplasia; 2013 Jan; 15(1):73-84. PubMed ID: 23359207
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. EGFRvIII and c-Met pathway inhibitors synergize against PTEN-null/EGFRvIII+ glioblastoma xenografts.
    Lal B, Goodwin CR, Sang Y, Foss CA, Cornet K, Muzamil S, Pomper MG, Kim J, Laterra J.
    Mol Cancer Ther; 2009 Jul; 8(7):1751-60. PubMed ID: 19584231
    [Abstract] [Full Text] [Related]

  • 4. The plasticity of oncogene addiction: implications for targeted therapies directed to receptor tyrosine kinases.
    Pillay V, Allaf L, Wilding AL, Donoghue JF, Court NW, Greenall SA, Scott AM, Johns TG.
    Neoplasia; 2009 May; 11(5):448-58, 2 p following 458. PubMed ID: 19412429
    [Abstract] [Full Text] [Related]

  • 5. Guanine nucleotide exchange factor Dock7 mediates HGF-induced glioblastoma cell invasion via Rac activation.
    Murray DW, Didier S, Chan A, Paulino V, Van Aelst L, Ruggieri R, Tran NL, Byrne AT, Symons M.
    Br J Cancer; 2014 Mar 04; 110(5):1307-15. PubMed ID: 24518591
    [Abstract] [Full Text] [Related]

  • 6. Translation of circHGF RNA encodes an HGF protein variant promoting glioblastoma growth through stimulation of c-MET.
    Saunders JT, Kumar S, Benavides-Serrato A, Holmes B, Benavides KE, Bashir MT, Nishimura RN, Gera J.
    J Neurooncol; 2023 May 04; 163(1):207-218. PubMed ID: 37162666
    [Abstract] [Full Text] [Related]

  • 7. Expression of hepatocyte growth factor/scatter factor and its receptor c-Met in brain tumors: evidence for a role in progression of astrocytic tumors (Review).
    Moriyama T, Kataoka H, Koono M, Wakisaka S.
    Int J Mol Med; 1999 May 04; 3(5):531-6. PubMed ID: 10202187
    [Abstract] [Full Text] [Related]

  • 8. In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis.
    Abounader R, Lal B, Luddy C, Koe G, Davidson B, Rosen EM, Laterra J.
    FASEB J; 2002 Jan 04; 16(1):108-10. PubMed ID: 11729097
    [Abstract] [Full Text] [Related]

  • 9. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
    Vengoji R, Macha MA, Nimmakayala RK, Rachagani S, Siddiqui JA, Mallya K, Gorantla S, Jain M, Ponnusamy MP, Batra SK, Shonka N.
    J Exp Clin Cancer Res; 2019 Jun 18; 38(1):266. PubMed ID: 31215502
    [Abstract] [Full Text] [Related]

  • 10. JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma.
    Zheng Q, Han L, Dong Y, Tian J, Huang W, Liu Z, Jia X, Jiang T, Zhang J, Li X, Kang C, Ren H.
    Neuro Oncol; 2014 Sep 18; 16(9):1229-43. PubMed ID: 24861878
    [Abstract] [Full Text] [Related]

  • 11. Multivariate signaling regulation by SHP2 differentially controls proliferation and therapeutic response in glioma cells.
    Furcht CM, Buonato JM, Skuli N, Mathew LK, Muñoz Rojas AR, Simon MC, Lazzara MJ.
    J Cell Sci; 2014 Aug 15; 127(Pt 16):3555-67. PubMed ID: 24951116
    [Abstract] [Full Text] [Related]

  • 12. Marked inhibition of glioblastoma target cell tumorigenicity in vitro by retrovirus-mediated transfer of a hairpin ribozyme against deletion-mutant epidermal growth factor receptor messenger RNA.
    Halatsch ME, Schmidt U, Bötefür IC, Holland JF, Ohnuma T.
    J Neurosurg; 2000 Feb 15; 92(2):297-305. PubMed ID: 10659018
    [Abstract] [Full Text] [Related]

  • 13. Nuclear phosphorylated Y142 β-catenin accumulates in astrocytomas and glioblastomas and regulates cell invasion.
    Náger M, Santacana M, Bhardwaj D, Valls J, Ferrer I, Nogués P, Cantí C, Herreros J.
    Cell Cycle; 2015 Feb 15; 14(22):3644-55. PubMed ID: 26654598
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Annexin A2-STAT3-Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma.
    Matsumoto Y, Ichikawa T, Kurozumi K, Otani Y, Fujimura A, Fujii K, Tomita Y, Hattori Y, Uneda A, Tsuboi N, Kaneda K, Makino K, Date I.
    Acta Neuropathol Commun; 2020 Apr 05; 8(1):42. PubMed ID: 32248843
    [Abstract] [Full Text] [Related]

  • 16. Analysis of phosphotyrosine signaling in glioblastoma identifies STAT5 as a novel downstream target of ΔEGFR.
    Chumbalkar V, Latha K, Hwang Y, Maywald R, Hawley L, Sawaya R, Diao L, Baggerly K, Cavenee WK, Furnari FB, Bogler O.
    J Proteome Res; 2011 Mar 04; 10(3):1343-52. PubMed ID: 21214269
    [Abstract] [Full Text] [Related]

  • 17. Role of hepatocyte growth factor activator (HGF activator) in invasive growth of human glioblastoma cells in vivo.
    Uchinokura S, Miyata S, Fukushima T, Itoh H, Nakano S, Wakisaka S, Kataoka H.
    Int J Cancer; 2006 Feb 01; 118(3):583-92. PubMed ID: 16106403
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. HGF regulates VEGF expression via the c-Met receptor downstream pathways, PI3K/Akt, MAPK and STAT3, in CT26 murine cells.
    Matsumura A, Kubota T, Taiyoh H, Fujiwara H, Okamoto K, Ichikawa D, Shiozaki A, Komatsu S, Nakanishi M, Kuriu Y, Murayama Y, Ikoma H, Ochiai T, Kokuba Y, Nakamura T, Matsumoto K, Otsuji E.
    Int J Oncol; 2013 Feb 01; 42(2):535-42. PubMed ID: 23233163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.